Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV000790879 | SCV000930105 | uncertain significance | Snijders Blok-Campeau syndrome | 2019-02-19 | criteria provided, single submitter | curation | This variant is interpreted as a Uncertain significance-Conflicting evidence for Snijders Blok-Campeau syndrome, autosomal dominant. The following ACMG Tag(s) were applied: PM2 : Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PM6-Strong : PM6 upgraded in strength to Strong (PMID:30397230). PM1-supporting : PM1 downgraded in strength to Supporting. PP2 : Missense variant in a gene that has a low rate of benign missense variation and in which missense variants are a common mechanism of disease. PP3 : Multiple lines of computational evidence support a deleterious effect on the gene or gene product. BS3 :Well-established in vitro or in vivo functional studies show no damaging effect on protein function or splicing (PMID:30397230). |
Institute of Human Genetics Munich, |
RCV000790879 | SCV004045898 | pathogenic | Snijders Blok-Campeau syndrome | 2022-09-21 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000790879 | SCV005368106 | likely pathogenic | Snijders Blok-Campeau syndrome | 2024-04-22 | criteria provided, single submitter | clinical testing | Criteria applied: PS4_MOD,PS2,PM2,PP2,PP3 |
CHU Sainte- |
RCV000714500 | SCV000787646 | likely pathogenic | Intellectual disability | 2018-05-03 | no assertion criteria provided | research |